Rule reference

Drugs & Cosmetics Act + NDPS Act — Hospital Narcotics & Expired Medicines

RULE_DRUGS_NDPS

Plain-language overview for organisations checking what may apply to them. This is a reference guide — not a substitute for the official gazette or legal advice.

← All compliance rulesWhat applies to my organisation? →

Drugs & Cosmetics Act + NDPS Act — Hospital Narcotics & Expired Medicines (RULE_DRUGS_NDPS)

Reference only — not legal advice. This page is EarthReheal WasteLedger's plain-language interpretation of the rule, written to help organisations understand what may apply to them. It can be incomplete or inaccurate. Always read the official gazette notification or statute, and confirm with your regulator or a qualified adviser, before relying on it for compliance decisions.

Quick Summary

EarthReheal WasteLedger's RULE_DRUGS_NDPS bundles two related but distinct legal regimes that hospitals typically face together: (1) the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 — pharmacy / drug-sale licensing, Schedule H / H1 controls, and general expired-medicine discipline; and (2) the Narcotic Drugs and Psychotropic Substances Act, 1985 and NDPS Rules, 1985 (as amended, notably by the Third Amendment Rules, 2015 — G.S.R. 359(E)), which created the Recognised Medical Institution (RMI) framework for stocking and dispensing Essential Narcotic Drugs (ENDs). A hospital pharmacy that dispenses morphine, fentanyl, or other ENDs needs State Drug Controller / FDA recognition (or deemed-RMI status for qualifying government hospitals), designated officer-in-charge, prescribed stock registers (Forms 3D / 3E / 3H), annual return Form 3I by 31 March, and witnessed destruction of expired ENDs. Separately, discarded / expired medicines (including cytotoxics) must follow Bio-Medical Waste Management Rules Schedule I pathways — never general MSW or drains. NDPS Act violations can carry serious criminal liability; treat this rule family as high-severity compliance, not paperwork theatre.

What This Rule Is

Full name (EarthReheal WasteLedger label): Drugs & Cosmetics Act + NDPS Act — Hospital Narcotics & Expired Medicines.

Important framing: This is a bundled EarthReheal WasteLedger rule code. Customers should not read it as a single merged statute. The Drugs Act/Rules and the NDPS Act/Rules have different purposes, forms, regulators' day-to-day desks, and penalty logic — but hospital pharmacy operations encounter them in the same physical store room.

A. Drugs and Cosmetics Act, 1940 / Rules, 1945

What it governs (hospital-relevant slice): licensing for manufacture, sale, and distribution of drugs; conditions attached to retail / wholesale / hospital pharmacy licences; prescription-only schedules (Schedule H, Schedule H1, Schedule X among others); labelling; and record-keeping for specified supplies.

Schedule H1 (verified via PIB / Rules practice): introduced by Gazette notification G.S.R. 588(E) dated 30 August 2013. Supply of a Schedule H1 drug must be recorded in a separate register at the time of supply, giving the name and address of the prescriber, the name of the patient, the name of the drug, and the quantity supplied; such records shall be maintained for three years and be open for inspection. Schedule H1 labelling carries the red Rx and the prescribed warning box. This register is separate from NDPS Essential Narcotic Drug registers.

Hospital pharmacy licensing: hospitals that store and dispense drugs generally require the appropriate licence(s) under the Drugs Rules from the State Licensing Authority / State Drug Controller (nomenclature varies — FDA Commissioner in some states). Exact licence form numbers and conditions are state-administered under the central Rules framework — confirm your current licence category with the state FDA.

B. NDPS Act, 1985 / NDPS Rules, 1985 (as amended)

What it governs: control of narcotic drugs and psychotropic substances, balancing prevention of illicit traffic with medical and scientific use. The NDPS (Amendment) Act, 2014 and subsequent Rules amendments (especially G.S.R. 359(E), 5 May 2015 — Narcotic Drugs and Psychotropic Substances (Third Amendment) Rules, 2015) created a nationally more uniform pathway for medical opioids via Essential Narcotic Drugs and Recognised Medical Institutions.

Essential Narcotic Drugs (ENDs): opioids notified for medical use. NCG / Pallium India RMI guidelines (summarising the post-amendment framework) list notified ENDs as including Morphine, Methadone, Codeine, Hydrocodone, Oxycodone, and Fentanyl. Always confirm the current notified list with the Department of Revenue / State Drug Controller — lists can be amended by notification.

Recognised Medical Institution (RMI): a medical institution authorised by the State Drug Controller / FDA Commissioner to possess, dispense, or sell Essential Narcotic Drugs for medical purposes under Chapter VB of the NDPS Rules (as inserted/amended in 2015).

Key Rule mechanics (from NDPS Rules as amended — corroborated via Indian Kanoon / G.S.R. 359(E) text and NCG guidelines):

  • Rule 52N — Deemed RMI: Government or Municipal Corporation or Municipal Council or Zilla Parishad hospital, dispensary, or medical institution that meets the Rule's criteria (including at least one registered medical practitioner with the required training in pain relief and palliative care, or in opioid substitution therapy as applicable) shall be deemed a recognised medical institution. Explanation clarifies that such government/local-body institutions are exempt from making application for recognition — they are not exempt from the other RMI obligations (registers, annual return, storage, training, etc.).
  • Rule 52-O — Private (and other non-deemed) institutions: apply in Form 3F to the Controller of Drugs; Certificate of Recognition issued in Form 3G, typically within 60 days of application receipt (or reasons for delay informed); recognition for a period not exceeding three years; renewal application at least 60 days before expiry.
  • Officer-in-charge: designate a registered medical practitioner (or dentist where applicable) trained in the medical use of ENDs / pain relief and palliative care / OST as required, responsible for stocking and dispensing oversight.
  • Records:
  • Form 3D — daily accounts of ENDs (ward / sub-storage / authorised person daily accounts — also used by registered medical practitioners and authorised persons under the Rules).
  • Form 3E — per-patient record of ENDs dispensed; preserve minimum two years from the date of last entry.
  • Form 3H — daily accounts of ENDs at the RMI main storage.
  • Retain stock registers generally two years from last entry (per Rules / NCG summary).
  • Form 3I — Annual return to the Controller of Drugs before 31 March every year — NCG guidelines emphasise filing even if no ENDs were used in the preceding year.
  • Expired ENDs: destroyed by the RMI in the presence of an officer nominated by the Controller of Drugs (Rule language corroborated in Rules text and NCG guidelines).
  • Purchase: only from authorised dealers / chemists.
  • Non-transfer: ENDs shall not be transferred, loaned, or sold to other institutions without prior approval of the Controller of Drugs.
  • Safe storage: NCG guidelines describe practical expectations such as a double-locking system (e.g., cupboard with two locks) — treat detailed hardware specs as guideline/practice unless your state circular mandates a specific standard.

Issuing / authorising authority for RMIs: State Drug Controller / Commissioner of Food & Drug Administration — a single state agency model after the 2014/2015 reforms (replacing the older multi-licence maze for medical opioids that NCG materials describe historically).

Legislative lineage (high level):

  • Drugs and Cosmetics Act, 1940; Drugs and Cosmetics Rules, 1945 (as amended over decades; Schedule H1 via G.S.R. 588(E), 2013).
  • NDPS Act, 1985; NDPS Rules, 1985; NDPS (Amendment) Act, 2014 (medical/scientific use emphasis; END concept); NDPS (Third Amendment) Rules, 2015 — G.S.R. 359(E) (RMI Chapter / Forms 3F–3I framework).

Policy purpose: ensure patients (especially palliative care, cancer pain, perioperative, and OST patients) can access essential opioids legally and safely, while preventing diversion; and ensure ordinary pharmacy stocks (including Schedule H1 antibiotics and habit-forming drugs) are dispensed with prescription discipline and auditable registers. Expired and cytotoxic medicines are steered into BMW treatment pathways so they do not re-enter the consumer chain or the environment via MSW/drains.

Who This Applies To

NDPS / RMI track — applies when: a healthcare facility possesses, stocks, or dispenses Essential Narcotic Drugs (or other NDPS-controlled substances under applicable licences). EarthReheal WasteLedger's healthcare org-pack treats RULE_DRUGS_NDPS as conditional on having a pharmacy/dispensary handling NDPS-scheduled controlled substances (hasNdpsDispensary).

Deemed vs applied RMI:

  • Government / Municipal / Zilla Parishad hospitals meeting Rule 52N criteria → deemed RMIs (no Form 3F application for recognition), but still must meet training, storage, register, annual-return, and destruction obligations.
  • Private hospitals and other non-deemed medical institutions → must apply (Form 3F) and hold a valid Form 3G recognition before possessing/dispensing ENDs as an RMI.

Drugs Act / Schedule H–H1 track — applies when: the facility operates a licensed pharmacy / dispensary supplying Schedule H / H1 / X drugs (nearly every hospital pharmacy), independent of whether ENDs are stocked.

Expired / discarded medicines track — applies to: every HCF that generates discarded medicines, including those without an END stock — via BMW Rules Schedule I (and manufacturer-return options where used), cross-referenced here because EarthReheal WasteLedger groups expired-medicine disposal checks under this rule code alongside narcotics controls.

*Who is not covered by RMI alone: manufacturers and wholesale dealers of narcotics have separate NDPS / Drugs licensing paths; individual registered medical practitioners have related but distinct possession limits and Form 3D duties under the Rules — this Bible focuses on institution / hospital* obligations.

State-Level Variations

The NDPS Rules Chapter on RMIs and ENDs is a central framework intended to apply uniformly across India (a core purpose of the 2014/2015 reforms). Forms 3D–3I and the RMI concept are nationally framed.

Where variation is real:

  • Administration is state-wise. The authorising officer is the State Drug Controller / FDA Commissioner of the state (or UT equivalent) where the institution sits. Inspection calendars, portal vs paper filing, and local circulars differ.
  • Some states may issue additional circulars on RMI inspection checklists, training certificate recognition, or annual-return submission mechanics. Confirm with your state FDA whether any circular supplements G.S.R. 359(E).
  • Drugs Act pharmacy licensing has always been state-administered; licence fee schedules, inspection SOPs, and online licence portals vary by state even though Schedules H/H1/X are central.
  • Witnessed destruction logistics (who is nominated as the witnessing officer, how to request a date) are practical state FDA procedures — plan ahead; do not assume a same-week slot.

Bottom line: legal architecture is national; your compliance counterparty and filing mechanics are state FDA / Drug Controller. Multi-state hospital groups need recognition/licence status per state (and typically per institution), not one pan-India RMI letter.

Compliance Requirements — What You Actually Have to Do

Part 1 — Essential Narcotic Drugs / RMI (NDPS Rules)

1. Determine whether you need RMI status. If you stock or dispense ENDs (morphine, fentanyl, etc.), you need either deemed status under Rule 52N (qualifying government/local-body hospitals) or a Form 3G Certificate of Recognition obtained via Form 3F.

2. Private institutions — apply and renew. Submit Form 3F with supporting documents (institution details, officer-in-charge, training evidence, storage description, estimated annual requirement — NCG guidelines also reference Form 3J annual requirement particulars in the application pack). Recognition ≤ 3 years; apply for renewal ≥ 60 days before expiry.

3. Designate the officer-in-charge of stocking/dispensing ENDs — a registered medical practitioner (or dentist where applicable) with the required pain relief and palliative care or OST training. Notify the Controller within the Rules' timelines if the officer changes (NCG guidelines: intimate within seven days for re-endorsement practice — confirm exact Rule/circular timing with your state FDA).

4. Maintain prescribed registers:

  • Form 3H — main storage daily accounts.
  • Form 3D — ward / sub-storage daily accounts.
  • Form 3E — per-patient dispensing record.
  • Retain two years from last entry; produce on inspection.

5. File annual return Form 3I before 31 March every year, including nil-use years.

6. Purchase only from authorised dealers/chemists; keep invoices and order records with the END file.

7. Do not transfer ENDs to other institutions without written permission of the Drugs Controller.

8. Destroy expired ENDs only in the presence of the official designated/nominated by the State Drug Controller. EarthReheal WasteLedger tracks this as witnessed-destruction evidence. Never quietly discard ENDs into BMW bags without that witnessed process.

9. Storage and diversion controls. Keep ENDs under secure storage (double lock as commonly guided), reconcile balances daily, investigate shortages immediately, and limit prescribing to designated trained practitioners for registered patients as required.

Part 2 — Drugs Act pharmacy / Schedule H1

10. Hold a valid pharmacy / drug licence appropriate to hospital dispensing under the Drugs and Cosmetics Rules; renew on the state FDA cycle.

11. Maintain Schedule H1 supply register (prescriber name & address, patient name, drug name, quantity) with three-year retention — separate from END Forms 3D/3E/3H.

12. Dispense Schedule H / H1 / X drugs only against valid prescriptions (and Schedule X duplicate-prescription rules where applicable). Preserve required prescription copies for the retention period in the Rules.

Part 3 — Expired / discarded medicines (BMW + Drugs interface)

13. Never dispose expired medicines in general MSW or drains.

14. Cytotoxic drugs: Yellow BMW stream under Schedule I; return to manufacturer or incineration / plasma pyrolysis at >1200°C or disposal at hazardous waste TSDF as provided in BMW Schedule I options — confirm the exact Schedule I row text and your CBWTF's authorised capability.

15. Other discarded medicines: return to manufacturer or incineration via CBWTF per BMW Schedule I.

16. Keep disposal evidence (CBWTF manifests, manufacturer take-back acknowledgements) with pharmacy and BMW files. EarthReheal WasteLedger maps expired-medicine disposal evidence under this rule code alongside NDPS tasks.

17. Do not confuse pathways: expired ENDs → NDPS witnessed destruction before/with Controller-nominated officer; expired non-END medicines → BMW Schedule I / manufacturer return; Schedule H1 register → Drugs Rules (3-year retention). Mixing these three systems is a common audit failure.

Penalties & Enforcement

NDPS Act: Violations involving narcotic drugs and psychotropic substances can attract serious criminal liability, including imprisonment. Historical commentary (including NCG materials discussing the pre-reform chilling effect) notes that even clerical failures were feared because of harsh penalty architecture — the 2014/2015 reforms improved medical access procedures, but they did not make diversion or unauthorised possession a trivial matter. Exact sentencing tables (quantities, commercial quantity thresholds, and section-wise terms) are fact-specific and amendable — confirm in the current NDPS Act. For any incident (shortage, theft, unauthorised transfer), involve counsel and notify the competent authority as required — do not "fix the register quietly."

Drugs and Cosmetics Act / Rules: Licensing violations, Schedule H1 register failures, and sale-without-prescription breaches attract regulatory action by the State Drug Controller / FDA — suspension or cancellation of licence, prosecutions under the Drugs Act as applicable. These are separate from NDPS criminal exposure.

BMW Rules: Improper disposal of expired or cytotoxic medicines can trigger SPCB enforcement under BMW Rules and Environment (Protection) Act powers — see RULE_BMW_2016.

Practical severity ranking for hospital leadership: unauthorised END possession/dispensing and diversion sit at the top of the risk register; missing Form 3I or incomplete 3E records are still serious regulatory failures; dumping expired medicines in MSW is an environmental and BMW failure that is easier for inspectors to spot than many paper gaps.

Frequently Asked Questions

Q: For example: if a private healthcare facility only rarely needs morphine — can it borrow ampoules from the government hospital next door? A: ENDs are not transferable between institutions without prior written approval of the Controller of Drugs. Informal borrowing is a classic diversion/compliance failure. Either obtain RMI recognition and purchase from authorised dealers, or use lawful emergency/authorisation pathways your state FDA recognises — do not "borrow."

Q: For example: if a government district hospital never applied on Form 3F — is it operating illegally? A: Under Rule 52N, qualifying Government / Municipal / Zilla Parishad institutions are deemed RMIs and are exempt from the application step — but only if they meet the Rule's practitioner-and-training criteria and still comply with registers, annual return, storage, and destruction rules. Deemed status is not a holiday from Form 3I or stock accounts. Confirm with the state FDA that the institution type is covered and that training evidence is in order.

Q: Is the Schedule H1 register the same as the NDPS Form 3H? A: No. Schedule H1 is a Drugs Rules supply register (typically 3-year retention). Forms 3D / 3E / 3H are NDPS END accounts (2-year retention from last entry). Keep them separate.

Q: What if we used zero ENDs this year — skip Form 3I? A: NCG guidelines stating Rules practice say file Form 3I before 31 March even if no ENDs were used. Treat nil returns as mandatory unless your state FDA gives written contrary advice.

Q: Can we destroy expired morphine tablets by putting them in the yellow BMW bag for the CBWTF? A: Expired ENDs require destruction in the presence of an officer nominated by the Controller of Drugs. Do not substitute ordinary BMW incineration for that witnessed NDPS process. Non-END expired medicines follow BMW Schedule I / manufacturer-return routes.

Q: How long is RMI recognition valid? A: Certificate of Recognition is issued for a period not exceeding three years at a time; renew via Form 3F at least 60 days before expiry.

Q: Which training certificate does the officer-in-charge need? A: Rules require training in pain relief and palliative care for END prescribing for pain/palliative use, or opioid substitution therapy training where ENDs are for treatment of opioid dependence. Exact certified courses recognised by your state FDA can vary — obtain written clarity from the state Drugs Control Department rather than assuming any CME certificate suffices.

Q: Does this EarthReheal WasteLedger rule replace our BMW authorisation? A: No. BMW authorisation and colour-stream duties remain under RULE_BMW_2016. This rule adds pharmacy licensing, Schedule H1, RMI/END controls, and the expired-medicine disposal evidence path.

Government / Official Sources

  • Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 (as amended) — pharmacy licensing; Schedule H / H1 / X. Schedule H1 conditions summarised in PIB release: Rules for Selling of Drugs Under Schedule H1 (G.S.R. 588(E), 30-08-2013).
  • Narcotic Drugs and Psychotropic Substances Act, 1985 (as amended, including 2014 medical-use reforms).
  • NDPS Rules, 1985 as amended by Narcotic Drugs and Psychotropic Substances (Third Amendment) Rules, 2015 — G.S.R. 359(E), 5 May 2015 — RMI Chapter; Forms 3F, 3G, 3D, 3E, 3H, 3I; Rule 52N deemed RMIs. Department of Revenue archive entry: dor.gov.in — G.S.R. 359(E). Consolidated Rules text (verify against official gazette for litigation use): Indian Kanoon — NDPS Rules, 1985.
  • Bio-Medical Waste Management Rules, 2016 — Schedule I — cytotoxic and discarded-medicine treatment/disposal options (yellow stream; return to manufacturer; incineration / plasma pyrolysis / TSDF as specified). Cross-check primary BMW text via CPCB BMW rules page or SPCB-hosted gazette PDFs.

Note: Always verify the live notified END list, any post-2015 Rule amendments, and your state FDA's circulars before freezing SOPs. NCG/Pallium guides are highly useful practice summaries but are not a substitute for the gazette text in a dispute.

Related Rules

  • RULE_BMW_2016 — Bio-Medical Waste Management Rules, 2016 — yellow-bag cytotoxic / discarded-medicine pathways; CBWTF handover; annual BMW reporting. Primary cross-reference for non-END expired medicines.
  • RULE_CEA_2010 — Clinical Establishments (Registration and Regulation) Act / related clinical-establishment compliance — may intersect hospital licensing and pharmacy service expectations depending on state adoption; do not treat it as a substitute for Drugs/NDPS licences.
  • RULE_HWM_2016 — Hazardous and Other Wastes Rules — relevant where cytotoxic or pharmaceutical waste is routed to a TSDF under BMW Schedule I options rather than CBWTF incineration alone.

Each of these has or will have its own Rule Bible entry; cross-reference rather than duplicate their full detail here.

Additional Reference Content

Secondary sources (law firm explainers, news, consultancy blogs, or official-body sites on a non-.gov.in/.nic.in domain) — useful context, not primary legal authority.

Looking for which rules apply to your organisation type? See the interactive coverage picker on the compliance coverage page.